2007
DOI: 10.1007/s11095-007-9403-4
|View full text |Cite
|
Sign up to set email alerts
|

Novel Biocompatible Cationic Copolymers Based on Polyaspartylhydrazide Being Potent as Gene Vector on Tumor Cells

Abstract: Finally, in vivo application studies confirmed the biocompatibility of PAHy-CPTA copolymers. With LPEI, clear signs of microvesicular fatty liver were observed and with LPEI polyplexes significant weight loss. In strong contrast, PAHy-CPTA did not induce histopathological changes or weight loss.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2007
2007
2022
2022

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 18 publications
0
4
0
Order By: Relevance
“…In contrast, LPEI and BPEI complexes resulted in an increase in liver enzyme levels, indicating beginning necrotic changes in liver tissue already after 24 h consistent with previous literature. 27,37 The…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, LPEI and BPEI complexes resulted in an increase in liver enzyme levels, indicating beginning necrotic changes in liver tissue already after 24 h consistent with previous literature. 27,37 The…”
Section: Discussionmentioning
confidence: 99%
“…Low molecular weight linear PEI-grafted cyclodextrin, polyaspartamide, chitosan, and dextrane have also been used as highly efficient and less toxic gene carriers . However, although many polyaspartamide-derived polycations have been applied to in vitro gene delivery, the transfection efficiencies are often relatively low . We here report oligo-ethylenimine brushes, a new kind of polycation, as polymer gene delivery vectors.…”
Section: Introductionmentioning
confidence: 97%
“…Both, cationic lipids and polycations can induce mild to severe liver damage, mainly microvesicular fatty liver. [ 43 ] The histopathological analysis of examined organs from OH4:DOPE NP4 pDNA lipoplex treated and control animals demonstrated healthy and physiological cell and tissue structures (Figure S22, Supporting Information). In the liver there were no obvious alterations, as no fatty liver degeneration or alteration of hepatocytes was visible.…”
Section: Resultsmentioning
confidence: 99%